Cargando…
New insights into cervical cancer screening
Worldwide, cervical cancer is a leading cause of cancer related morbidity and mortality. For over 50 years, cervical cytology has been the gold standard for cervical cancer screening. Because of its profound effect on cervical cancer mortality in nations that have adopted screening programs, the Pap...
Autores principales: | Boone, Jonathan D., Erickson, Britt K., Huh, Warner K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gynecologic Oncology and Colposcopy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469864/ https://www.ncbi.nlm.nih.gov/pubmed/23094132 http://dx.doi.org/10.3802/jgo.2012.23.4.282 |
Ejemplares similares
-
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014) -
Increased disparities associated with black women and abnormal cervical cancer screening follow-up
por: Boitano, Teresa K.L., et al.
Publicado: (2022) -
A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Benard, Vicki B., et al.
Publicado: (2021) -
Glycosylation in Cervical Cancer: New Insights and Clinical Implications
por: Xu, Zhiwei, et al.
Publicado: (2021) -
The role of human papillomavirus testing after treatment for high-grade cervical dysplasia
por: Turner, Taylor B, et al.
Publicado: (2016)